Go to main page

Evaluate Your Novel Anti-Cancer Agents in a Timely and Cost-Effective Manner

Receive a 20% discount on your first cell line-derived xenograft (CDX) study with BioDuro

Offer is available through December 31, 2018

Get Introductory Pricing

Save 20% on Your First Cell Line-Derived Xenograft (CDX) Study With BioDuro

We invite new clients to conduct a CDX study with BioDuro Oncology, backed by 13 years of CRO experience in oncology and drug discovery, with a special introductory 20% discount.

300+ Cancer Cell Lines and 80 Validated CDX Models

Well-established and widely used models for preclinical testing of anti-cancer drug efficacy

Subcutaneous, Orthotopic and Experimental Metastatic Models

Intravenous, subcutaneous or orthotopic implantation into immunodeficient mice

32 Luciferase Labeled Cell Lines and In Vivo Models

Non-invasive tools for studying disease progression

In Vivo Bioluminescent and Fluorescent Imaging

Increased robustness, signal-to-noise ratio and faster kinetics

Enroll and Save on a CDX Study Today!

Explore how we can meet your preclinical oncology research needs, contact us directly.

    You may unsubscribe from these communications at any time. Every email we send you will also include an unsubscribe link so you can unsubscribe from our marketing list. For more information on our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.
Landing_Page_Content_CDX_Introductory_Discount-01

Advance efficacy studies of your novel agents today

Cell Line-Derived Xenograft (CDX) models have been widely used for preclinical studies of drug efficacy, PK/PD correlation and combination therapy.
CDX models are established from a variety of tumor cell lines that are grown in culture and inoculated in immunodeficient mice, where tumors are rapidly formed. The cells can be implanted intravenously, subcutaneously or orthotopically. CDX models provide an effective method of study into the efficacy of novel agents in inhibiting tumor growth and mechanisms of action.

20% discount for new clients is available through December 31, 2018

Terms and Conditions: Offer valid through December 31, 2018. Offer may not be applied to existing, pending or previous orders. Offer cannot be combined with any additional discounts or promotions. We reserve the right to change the terms and conditions of this promotion without notice.